Product image of Latalux (Latanoprost) supplied by GNH India

Latalux

Active Ingredient:
Latanoprost
Origin:
EU

Latalux (Latanoprost)

Latanoprost, the active ingredient in Latalux, is a prostaglandin analog presented as eye drops for ocular use. It lowers intra‑ocular pressure and is indicated for the management of open‑angle glaucoma and ocular hypertension in adult patients. By enhancing uveoscleral outflow of aqueous humor, the medication helps preserve visual function and prevent disease progression.

GNH India supplies Latalux as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Manufacturer / TM Owner

Bausch + Lomb Ireland Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Latalux (latanoprost) is employed in ocular conditions where lowering intra‑ocular pressure is essential to protect the optic nerve, maintain visual field, and prevent disease progression.

  • Open‑angle glaucoma: decreases intra‑ocular pressure by increasing aqueous humor outflow, thereby slowing progression of optic nerve damage and preserving visual field.
  • Ocular hypertension: lowers elevated eye pressure in patients without established glaucoma, reducing the risk of future glaucomatous damage.

How It Works

  • Latanoprost is a synthetic analogue of prostaglandin F₂α that binds to FP receptors on the ciliary muscle. Activation of these receptors remodels the extracellular matrix, enhancing uveoscleral outflow of aqueous humor. The increased drainage reduces intra‑ocular pressure, providing therapeutic control of glaucoma and ocular hypertension. The effect is sustained with once‑daily dosing, and the drug exhibits minimal systemic absorption, focusing its action within the eye.

Side Effects

Latanoprost may cause ocular and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Eye redness: transient conjunctival hyperemia.
  • Increased eyelash growth: longer, thicker lashes.
  • Iris darkening: gradual change in eye color.
  • Eye irritation: foreign body sensation or mild discomfort.

Serious or Rare Side Effects

  • Uveitis: inflammation of the uveal tract.
  • Macular edema: swelling of the central retina.
  • Severe allergic reaction: contact dermatitis or swelling.

Precautions & Warnings

When prescribing Latalux, clinicians should consider several safety measures to minimize risk and ensure optimal therapeutic outcome.

  • Baseline intra‑ocular pressure assessment: measure IOP before initiating therapy.
  • Monitor iris color changes: observe for gradual darkening during treatment.
  • Avoid use in active ocular inflammation: contraindicated in uveitis or infection.
  • Caution in patients with herpetic eye disease: may trigger reactivation.
  • Do not combine with other prostaglandin analog eye drops: increased risk of side effects.
  • Store at room temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Latalux can interact with other ophthalmic agents, affecting efficacy or safety.

Major Interactions (Avoid)

  • Other prostaglandin analog eye drops: additive ocular side effects and unpredictable pressure changes.
  • Systemic carbonic anhydrase inhibitors: may potentiate intra‑ocular pressure reduction leading to hypotony.

Moderate Interactions (Monitor Closely)

  • Beta‑blocker eye drops: monitor intra‑ocular pressure for additive effect.
  • Anticholinergic eye drops: observe for changes in ocular surface tolerance.
  • Topical corticosteroids: watch for increased risk of cataract formation.
  • Non‑steroidal anti‑inflammatory eye drops: may reduce prostaglandin efficacy.

Frequently Asked Questions

Latalux contains latanoprost, a prostaglandin analog indicated for reducing intra‑ocular pressure in adults with open‑angle glaucoma or ocular hypertension, helping to prevent optic nerve damage and preserve vision.

Latanoprost mimics prostaglandin F₂α and binds to FP receptors in the ciliary body, remodeling the extracellular matrix and increasing uveoscleral outflow of aqueous humor, which lowers intra‑ocular pressure.

The prescribed dose is determined by the treating ophthalmologist, typically one drop in the affected eye(s) once daily in the evening, but exact dosing must follow the clinician’s instructions.

Safety data are limited; the product is classified as pregnancy category unknown. It should be used only if the potential benefit justifies the potential risk to the fetus, and breastfeeding mothers should consult their healthcare provider.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and required import documentation.

Latalux (latanoprost) is a prostaglandin analog, generally offering once‑daily dosing and a favorable efficacy profile compared with beta‑blocker or carbonic anhydrase inhibitor drops, though individual response and side‑effect tolerance may vary.

Store the eye‑drop bottles at room temperature, below 25 °C, in the original packaging, protected from light and moisture. Keep the container tightly closed and discard any product that appears discolored or contaminated.

Latalux is applied as a single drop to the conjunctival sac of the affected eye(s) in the evening, avoiding contact with the tip of the bottle and washing hands before and after use.

Although uncommon, serious adverse events include uveitis, macular edema, and severe allergic reactions such as contact dermatitis; patients should seek immediate medical attention if they experience pain, vision changes, or significant inflammation.

Latalux is contraindicated in patients with active ocular infection or inflammation, known hypersensitivity to latanoprost or any component of the formulation, and should be used with caution in individuals with a history of herpetic eye disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT